Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
BJU Int
    September 2017
  1. VETTERLEIN MW, Gild P, Kluth LA, Seisen T, et al
    Perioperative Allogeneic Blood Transfusion Does Not Adversely Impact Oncological Outcomes After Radical Cystectomy for Urinary Bladder Cancer - a Propensity Score-weighted European Multicenter Study.
    BJU Int. 2017 Sep 14. doi: 10.1111/bju.14012.
    >> Share

  2. LI R, Metcalfe MJ, Ferguson Rd JE, Mokkapati S, et al
    Effects of Thiazolidinedione in Patients with Active Bladder Cancer.
    BJU Int. 2017 Sep 5. doi: 10.1111/bju.14009.
    >> Share

  3. DUDDERIDGE T
    Positive messages for bladder cancer management in negative sentinel lymph node study.
    BJU Int. 2017;120:302-303.
    >> Share

  4. MARCHIONI M, Primiceri G, Cindolo L, Hampton LJ, et al
    Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.
    BJU Int. 2017;120:313-319.
    >> Share

  5. BLUTE ML JR, Kucherov V, Rushmer TJ, Damodaran S, et al
    Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2 ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression.
    BJU Int. 2017;120:387-393.
    >> Share

  6. CHAPPIDI MR, Kates M, Tosoian JJ, Johnson MH, et al
    Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database.
    BJU Int. 2017;120:377-386.
    >> Share

    August 2017
  7. WAINGANKAR N, Mallin K, Smaldone M, Egleston BL, et al
    Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy.
    BJU Int. 2017;120:239-245.
    >> Share

  8. MILLER C, Campain NJ, Dbeis R, Daugherty M, et al
    Introduction of robot-assisted radical cystectomy within an established enhanced recovery programme.
    BJU Int. 2017;120:265-272.
    >> Share

    June 2017
  9. MCCOMBIE SP, Bangash HK, Kuan M, Thyer I, et al
    Delays in the diagnosis and initial treatment of bladder cancer in Western Australia.
    BJU Int. 2017 Jun 29. doi: 10.1111/bju.13939.
    >> Share

  10. AFSHAR M, Goodfellow H, Jackson-Spence F, Evison F, et al
    Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': The case for super centralisation.
    BJU Int. 2017 Jun 8. doi: 10.1111/bju.13929.
    >> Share

  11. SOAVE A, Riethdorf S, Dahlem R, Minner S, et al
    Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
    BJU Int. 2017;119:854-861.
    >> Share

    May 2017
  12. NGO B, Papa N, Perera M, Bolton D, et al
    Bladder cancer diagnosis during haematuria investigation - implications for practice guidelines.
    BJU Int. 2017;119 Suppl 5:53-54.
    >> Share

  13. HAYNE D
    Bladder cancer - Old lessons yet to be learned.
    BJU Int. 2017;119 Suppl 5:7.
    >> Share

  14. NGO B, Perera M, Papa N, Bolton D, et al
    Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.
    BJU Int. 2017;119 Suppl 5:10-18.
    >> Share

  15. LAWRENTSCHUK N
    Bladder cancer- time for a higher profile in our region.
    BJU Int. 2017;119 Suppl 5:5.
    >> Share

  16. NGO B, Papa N, Perera M, Bolton D, et al
    Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.
    BJU Int. 2017;119 Suppl 5:19-25.
    >> Share

    April 2017
  17. HAYNE D, Stockler M, McCombie SP, Lawrence N, et al
    The BCG + Mitomycin trial for high risk non-muscle-invasive bladder cancer: Progress report and lessons learned.
    BJU Int. 2017 Apr 9. doi: 10.1111/bju.13873.
    >> Share

  18. BAILEY GC, Boorjian SA, Ziegelmann MJ, Westerman ME, et al
    Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma.
    BJU Int. 2017;119:585-590.
    >> Share

  19. HINATA N, Hussein AA, George S, Trump DL, et al
    Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.
    BJU Int. 2017;119:605-611.
    >> Share

    February 2017
  20. VESKIMAE E, Neuzillet Y, Rouanne M, MacLennan S, et al
    Systematic review of the oncological and functional outcomes of pelvic organ-preserving cystectomy compared with standard radical cystectomy in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
    BJU Int. 2017 Feb 20. doi: 10.1111/bju.13819.
    >> Share

    January 2017
  21. WOLDU SL, Bagrodia A, Lotan Y
    Guideline of Guidelines - Non-Muscle Invasive Bladder Cancer.
    BJU Int. 2017 Jan 6. doi: 10.1111/bju.13760.
    >> Share

  22. GOLOMBOS DM, O'Malley P, Lewicki P, Stone BV, et al
    Robot-assisted partial cystectomy: perioperative outcomes and early oncological efficacy.
    BJU Int. 2017;119:128-134.
    >> Share

    December 2016
  23. HUSSEIN AA, Hinata N, Dibaj S, May PR, et al
    Development, Validation and Clinical Application of Pelvic Lymphadenectomy Assessment and Completion Evaluation (PLACE): Intraoperative Assessment of Lymph Node Dissection after Robot-Assisted Radical Cystectomy for Bladder Cancer.
    BJU Int. 2016 Dec 17. doi: 10.1111/bju.13748.
    >> Share

    October 2016
  24. ALJABERY F, Shabo I, Olson H, Gimm O, et al
    Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer-a prospective clinical study.
    BJU Int. 2016 Oct 31. doi: 10.1111/bju.13700.
    >> Share

  25. FERNANDEZ MI, Williams SB, Willis DL, Slack RS, et al
    Clinical Risk Stratification in Patients with Surgically Resectable Micropapillary Bladder Cancer.
    BJU Int. 2016 Oct 18. doi: 10.1111/bju.13689.
    >> Share

  26. MATARAZA JM, Gotwals P
    Recent advances in immuno-oncology and its application to urological cancers.
    BJU Int. 2016;118:506-14.
    >> Share

  27. LONGO N, Imbimbo C, Fusco F, Ficarra V, et al
    Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy.
    BJU Int. 2016;118:521-6.
    >> Share

  28. ZHANG C, Ma X, Du J, Yao Z, et al
    MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1.
    BJU Int. 2016;118:578-89.
    >> Share

    July 2016
  29. ONISHI T, Sugino Y, Shibahara T, Masui S, et al
    Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle invasive bladder cancer.
    BJU Int. 2016 Jul 22. doi: 10.1111/bju.13599.
    >> Share

  30. LOTAN Y
    Analysis of genetics to identify susceptibility to secondary malignancies in patients with bladder cancer.
    BJU Int. 2016;118:12-3.
    >> Share

  31. MOSTAFID AH
    Time to re-evaluate and refine re-transurethral resection in bladder cancer?
    BJU Int. 2016;118:9-10.
    >> Share

    June 2016
  32. CUMBERBATCH MG, Shellard BW, Catto JW
    The contemporary landscape of occupational bladder cancer within the United Kingdom: A meta-analysis of risks over the last 80 years.
    BJU Int. 2016 Jun 22. doi: 10.1111/bju.13561.
    >> Share

  33. MEYER CP, Rios Diaz AJ, Dalela D, Hanske J, et al
    Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and implications for outcomes.
    BJU Int. 2016;117.
    >> Share

    May 2016
  34. HURLE R, Pasini L, Lazzeri M, Colombo P, et al
    Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project.
    BJU Int. 2016 May 21. doi: 10.1111/bju.13536.
    >> Share

  35. KAMAT AM, Willis DL, Dickstein RJ, Anderson R, et al
    Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guerin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies.
    BJU Int. 2016;117:754-60.
    >> Share

    April 2016
  36. VARTOLOMEI MD, Kiss B, Vidal A, Burkhard F, et al
    Long-term results of a prospective randomized trial assessing the impact of re-adaptation of the dorsolateral peritoneal layer after extended pelvic lymph node dissection and cystectomy.
    BJU Int. 2016;117:618-28.
    >> Share

  37. CHEN EC, Papa N, Lawrentschuk N, Bolton D, et al
    Incidence and risk factors of venous thromboembolism after pelvic uro-oncologic surgery--a single center experience.
    BJU Int. 2016;117 Suppl 4:50-3.
    >> Share

    March 2016
  38. YADAV S, Tomar V, Yadav SS, Priyadarshi S, et al
    Role of oral PentosanPolysulphate in reduction of local side effects of BCG in Non muscle invasive Bladder Cancer patients: a pilot study.
    BJU Int. 2016 Mar 24. doi: 10.1111/bju.13489.
    >> Share

  39. ODDENS JR, Sylvester RJ, Brausi MA, Kirkels WJ, et al
    Increasing age is not associated with toxicity leading to discontinuation of treatment in urothelial non muscle invasive bladder cancer patients randomized to receive 3 years of maintenance bacillus Calmette-Guerin: Results from EORTC GU Group study 3
    BJU Int. 2016 Mar 6. doi: 10.1111/bju.13474.
    >> Share

  40. SATKUNASIVAM R, Hu B, Metcalfe C, Ghodoussipour SB, et al
    Utility and significance of ureteric frozen section analysis during radical cystectomy.
    BJU Int. 2016;117:463-8.
    >> Share

    February 2016
  41. SAMMON JD, Abdollah F, Klett DE, Pucheril D, et al
    The diminishing returns of robotic diffusion: complications after robot-assisted radical prostatectomy.
    BJU Int. 2016;117:211-2.
    >> Share

  42. AZIZ A, Shariat SF, Roghmann F, Brookman-May S, et al
    Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    BJU Int. 2016;117:272-9.
    >> Share

  43. ZEHNDER P, Moltzahn F, Mitra AP, Cai J, et al
    Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes.
    BJU Int. 2016;117:253-9.
    >> Share

    December 2015
  44. KOUPPARIS A, Villeda-Sandoval C, Weale N, El-Mahdy M, et al
    Robot-assisted radical cystectomy with intracorporeal urinary diversion: impact on an established enhanced recovery protocol.
    BJU Int. 2015;116:924-31.
    >> Share

    November 2015
  45. ROLLE L, Falcone M, Ceruti C, Timpano M, et al
    A prospective multicentric international study on the surgical outcomes and patients' satisfaction rates of the "Sliding Technique" for end-stage Peyronie's disease with severe shortening of the penis and erectile dysfunction.
    BJU Int. 2015 Nov 11. doi: 10.1111/bju.13370.
    >> Share

  46. LOEB S, Ribal MJ
    Controversies in management of high-risk prostate and bladder cancer.
    BJU Int. 2015;116:675.
    >> Share

  47. SKINNER EC
    Is 42 days the 'magic number' for repeat transurethral resection of bladder tumour (TURBT)?
    BJU Int. 2015;116:678-9.
    >> Share

  48. TAN WS, Sridhar A, Goldstraw M, Zacharakis E, et al
    Robot-assisted intracorporeal pyramid neobladder.
    BJU Int. 2015;116:771-9.
    >> Share

  49. AL HUSSEIN AL AWAMLH B, Wang LC, Nguyen DP, Rieken M, et al
    Is continent cutaneous urinary diversion a suitable alternative to orthotopic bladder substitute and ileal conduit after cystectomy?
    BJU Int. 2015;116:805-14.
    >> Share

    October 2015
  50. GENDY R, Delprado W, Brenner P, Brooks A, et al
    Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
    BJU Int. 2015 Oct 21. doi: 10.1111/bju.13265.
    >> Share

  51. WARREN H, Raison N, Dasgupta P
    Pioglitazone and Bladder Cancer.
    BJU Int. 2015 Oct 15. doi: 10.1111/bju.13352.
    >> Share

  52. MULLER J, Grosclaude P, Lapotre-Ledoux B, Woronoff AS, et al
    Trends of the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10,047 patients.
    BJU Int. 2015 Oct 15. doi: 10.1111/bju.13351.
    >> Share

  53. RAMIREZ D, Gupta A, Canter D, Harrow B, et al
    Microscopic hematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer.
    BJU Int. 2015 Oct 5. doi: 10.1111/bju.13345.
    >> Share

  54. IZQUIERDO L, Peri L, Leon P, Ramirez-Backhaus M, et al
    The role of cystectomy in elderly patients - a multicentre analysis.
    BJU Int. 2015;116 Suppl 3:73-9.
    >> Share

    September 2015
  55. VOSKOBOYNIK M, Rudman S, Arkenau HT, Hughes S, et al
    Immunotherapy for Bladder Cancer: Rediscovering an Old Friend.
    BJU Int. 2015 Sep 21. doi: 10.1111/bju.13330.
    >> Share

  56. PATEL MI, Bang A, Gillatt D, Smith DP, et al
    Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study.
    BJU Int. 2015 Sep 2. doi: 10.1111/bju.13152.
    >> Share

    August 2015
  57. ROSE JB, Armstrong S, Hermann GG, Kjellberg J, et al
    Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue- light cystoscopy in trans-urethral bladder tumour resection for non-muscle invasive bladder cancer patients in Sweden.
    BJU Int. 2015 Aug 25. doi: 10.1111/bju.13261.
    >> Share

  58. WILLIAMS SB, Kamat AM, Lamm DL
    Pelvic recurrence after radical cystectomy: a call to arms.
    BJU Int. 2015;116:172-3.
    >> Share

    July 2015
  59. O'REGAN T, Tatton M, Lyon M, Masters J, et al
    The effectiveness of BCG and interferon against non-muscle invasive bladder cancer: A New Zealand Perspective.
    BJU Int. 2015 Jul 14. doi: 10.1111/bju.13211.
    >> Share

  60. GAKIS G, Stenzl A
    Can we rely on lymphovascular invasion for determining the need for adjuvant chemotherapy in organ-confined bladder cancer?
    BJU Int. 2015;116:3-4.
    >> Share

  61. WITJES JA
    Fluorescence cystoscopy: the end of biopsies for carcinoma in situ detection?
    BJU Int. 2015;116:2-3.
    >> Share

  62. VON RUNDSTEDT FC, Mata DA, Groshen S, Stein JP, et al
    Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
    BJU Int. 2015;116:44-9.
    >> Share

    June 2015
  63. ALBISINNI S, Rassweiler J, Abbou CC, Cathelineau X, et al
    Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology.
    BJU Int. 2015;115:937-45.
    >> Share

    May 2015
  64. MCLATCHIE LM
    Could a dye offer a cheap and simple approach to detect bladder cancer using white-light cystoscopy?
    BJU Int. 2015 May 8. doi: 10.1111/bju.13177.
    >> Share

  65. LUCCA I, Roupret M, Kluth L, Rink M, et al
    Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
    BJU Int. 2015;115:722-7.
    >> Share

  66. LEOW JJ, Reese S, Trinh QD, Bellmunt J, et al
    Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis.
    BJU Int. 2015;115:713-21.
    >> Share

  67. ISHIOKA J, Saito K, Kijima T, Nakanishi Y, et al
    Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    BJU Int. 2015;115:705-12.
    >> Share

    April 2015
  68. TOLCHARD S, Angell J, Pyke M, Lewis S, et al
    Cardiopulmonary reserve as determined by cardiopulmonary exercise testing correlates with length of stay and predicts complications after radical cystectomy.
    BJU Int. 2015;115:554-61.
    >> Share

  69. PHE V, Roupret M, Cussenot O, Chartier-Kastler E, et al
    Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patients.
    BJU Int. 2015;115 Suppl 6:28-32.
    >> Share

    December 2014
  70. BAACK KUKREJA JE, Scosyrev E, Brasacchio RA, Toy EP, et al
    Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer.
    BJU Int. 2014;114:844-51.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016